These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33450753)

  • 21. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics.
    Weinfurtner RJ; Patel B; Laronga C; Lee MC; Falcon SL; Mooney BP; Yue B; Drukteinis JS
    Clin Breast Cancer; 2015 Jun; 15(3):234-9. PubMed ID: 25579460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
    Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
    BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Breast Magnetic Resonance Imaging in Women Diagnosed With Atypical Ductal Hyperplasia at Core Needle Biopsy Helps Select Women for Surgical Excision.
    Amitai Y; Menes T; Golan O
    Can Assoc Radiol J; 2018 Aug; 69(3):240-247. PubMed ID: 29958833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
    Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
    World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management.
    Lilly AJ; Johnson M; Kuzmiak CM; Ollila DW; O'Connor SM; Hertel JD; Calhoun BC
    Ann Diagn Pathol; 2020 Oct; 48():151563. PubMed ID: 32738557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy.
    Chaudhary S; Lawrence L; McGinty G; Kostroff K; Bhuiya T
    Mod Pathol; 2013 Jun; 26(6):762-71. PubMed ID: 23307062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI of occult breast carcinoma in a high-risk population.
    Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
    AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US.
    LaTrenta LR; Menell JH; Morris EA; Abramson AF; Dershaw DD; Liberman L
    Radiology; 2003 Jun; 227(3):856-61. PubMed ID: 12773685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive values of BI-RADS(®) magnetic resonance imaging (MRI) in the detection of breast ductal carcinoma in situ (DCIS).
    Badan GM; Piato S; Roveda D; de Faria Castro Fleury E
    Eur J Radiol; 2016 Oct; 85(10):1701-1707. PubMed ID: 27666605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
    Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
    Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic resonance imaging.
    Mori N; Abe H; Mugikura S; Miyashita M; Mori Y; Oguma Y; Hirasawa M; Sato S; Takase K
    Breast Cancer; 2021 Sep; 28(5):1141-1153. PubMed ID: 33900583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing patterns of breast cancer on preoperative dynamic contrast-enhanced magnetic resonance imaging and resection margin in breast conserving therapy.
    Kim OH; Kim SJ; Lee JS
    Breast Dis; 2016 Feb; 36(1):27-35. PubMed ID: 27177341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of epithelial atypia in B3-lesions of the breast is associated with decreased risk for malignancy.
    Mayer S; Kayser G; Rücker G; Bögner D; Hirschfeld M; Hug C; Stickeler E; Gitsch G; Erbes T
    Breast; 2017 Feb; 31():144-149. PubMed ID: 27866089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of 16/18G core needle biopsy for ultrasound-visible breast lesions.
    Zhou JY; Tang J; Wang ZL; Lv FQ; Luo YK; Qin HZ; Liu M
    World J Surg Oncol; 2014 Jan; 12():7. PubMed ID: 24400744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
    Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
    Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
    Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
    Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.